Position in VCEL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$12,366,348
+$3,688,269 QoQ
Shares Held
277,958
+3.0% QoQ
Ownership
0.543%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. VCEL ranks #57 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in VCEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,366,348 | 277,958 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $8,678,079 | 269,757 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $10,242,573 | 284,437 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $9,237,132 | 293,522 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $12,928,983 | 303,854 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $13,384,344 | 299,963 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $16,987,614 | 309,372 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $12,914,640 | 305,672 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $16,353,187 | 356,434 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $17,880,519 | 343,724 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $12,800,795 | 359,472 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $12,435,983 | 371,002 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $14,251,124 | 379,322 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $11,410,226 | 389,162 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $10,592,917 | 402,161 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,695,858 | 417,925 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,280,739 | 408,290 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $17,555,742 | 459,334 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $17,686,766 | 450,045 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $22,830,151 | 467,831 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $23,328,373 | 444,350 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $25,777,197 | 464,036 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $6,957,045 | 225,293 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $3,444,521 | 185,889 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,696,031 | 195,082 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,782,051 | 194,335 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||